abstract |
The present invention relates to compounds having a 2,3-diphenylquinoxaline moiety that inhibit the activity of Akt, a serine / threonine protein kinase. The invention further relates to chemotherapeutic compositions comprising a compound of the invention, as well as to therapeutic methods comprising the step of administering a compound of the invention. |